Literature DB >> 24176479

Fever in immunocompromised hosts.

Devang M Patel1, David J Riedel.   

Abstract

Fever is one of the most common reasons for the emergency department presentation of immunocompromised patients. Their differential diagnosis can be broad and includes rare or unexpected pathogens. Certain infectious causes of fever portend true emergencies; if they are not managed appropriately, rapid progression and death may ensue. This article reviews the diagnosis and management of fevers in patients immunocompromised by human immunodeficiency virus/AIDS, solid-organ and hematopoietic transplants, chemotherapy-induced neutropenia, and tumor necrosis factor-α inhibitors. Prompt recognition of the type of immunosuppression and delineation of possible causes of fever are critical for management of these complex patients.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIDS; Emergency department; Fever; HIV; Hematopoietic stem cell transplant; Neutropenic fever; Solid-organ transplant; Tumor necrosis factor-α inhibitors

Mesh:

Substances:

Year:  2013        PMID: 24176479     DOI: 10.1016/j.emc.2013.07.002

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  3 in total

1.  Screening for dental focal infections in febrile patients with hematologic malignancies who received chemotherapy: a retrospective cohort study.

Authors:  Yasuyuki Shimada; Yohei Kawasaki; Ryo Nasu; Fumihiko Nakamura; Yutaka Maruoka
Journal:  Glob Health Med       Date:  2020-08-31

Review 2.  Immunomodulatory activity of Lactobacillus plantarum KLDS1.0318 in cyclophosphamide-treated mice.

Authors:  Yueyue Meng; Bailiang Li; Da Jin; Meng Zhan; Jingjing Lu; Guicheng Huo
Journal:  Food Nutr Res       Date:  2018-03-21       Impact factor: 3.894

3.  Agreement between diagnostic imaging methods for the evaluation of lymphadenopathies in HIV-infected/AIDS patients.

Authors:  Francisco Carlos da Silva; Gabriel Antonio Nascentes; Antonio Carlos Oliveira Meneses; Dalmo Correia Filho
Journal:  Radiol Bras       Date:  2019 Jan-Feb
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.